Veracyte

Veracyte is a global genomic diagnostics company founded in 2008 and headquartered in South San Francisco, California. The company develops and commercializes genomic tests that give clinicians high-confidence insights at critical diagnostic decision points in oncology. Its product portfolio includes the Afirma Genomic Sequencing Classifier for thyroid cancer, Decipher Prostate and Bladder Genomic Classifiers for urologic cancers, the Prosigna Breast Cancer Assay, and the Percepta Nasal Swab Test for lung cancer. Veracyte's tests enable physicians to avoid unnecessary surgeries and guide treatment decisions with greater precision. The company has grown through acquisitions and partnerships to serve patients and clinicians across multiple cancer types globally.